Alpha Dna Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Alpha Dna Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $667,821 - $799,593	1,947 New	1,947 $792,000
Q4 2022 Jan 27, 2023	BUY	$285.76 - $321.48 $1.32 Million - $1.48 Million	4,615 New	4,615 $0
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $47,247 - $55,717	-252 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $3,933 - $4,584	-19 Reduced 7.01%	252 $54,000
Q4 2020 Mar 24, 2021	BUY	$207.01 - $276.09 $4,554 - $6,073	22 Added 8.84%	271 $64,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $51,545 - $68,746	249 New	249 $58,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.